Parkside Financial Bank & Trust »

Abcellera Biologics shares owned by Parkside Financial Bank & Trust

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Parkside Financial Bank & Trust from 13F filings

Historical chart of Parkside Financial Bank & Trust investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Parkside Financial Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Parkside Financial Bank & Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1k 200 5.71

More positions owned by Parkside Financial Bank & Trust

Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Microsoft Corporation (MSFT)
Jpmorgan Chase & Co Alerian Ml Etn (AMJ)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Parkside Financial Bank & Trust

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics